
Everolimus 0.5 mg (Advacan) is an immunosuppressant medicine used primarily to help prevent organ transplant rejection, especially after kidney or liver transplantation. It works by reducing the activity of the immune system, lowering the risk of the body attacking the transplanted organ. It should be taken exactly as prescribed and under close medical supervision.
| Generic name | Everolimus |
| Strength | 0.5 mg |
| Manufacturer | Eris Lifesciences |
| Package size | 10 Tablets |
| Used for | Breast, Lung, Pancreatic, Kidney cancer and Prevention of organ rejection in transplant patients |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Everolimus is an mTOR (mammalian target of rapamycin) inhibitor. It suppresses the activity of immune cells, particularly T lymphocytes, preventing them from attacking the transplanted organ. This helps reduce the risk of organ rejection and supports successful transplantation.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.